具有耐药性和智力障碍的成年人的适应性和认知轨迹
Hadassa Kwetsie1, Jans S van Ool2, Francesca M Snoeijen-Schouwenaars2
1Emma Children's Hospital, Amsterdam University Medical Centers, Amsterdam, the Netherlands; Advisium, 's Heeren Loo, Amersfoort, the Netherlands.
Epilepsy & behavior : E&B
|March 9, 2026
概括
患有和智力障碍 (ID) 的成年人经历了随着时间的推移,适应性功能显著下降. 这凸显了对这一弱势群体提高认识和定期评估的必要性.
科学领域:
- 神经学 神经学
- 发育障碍 发育障碍是一种发展障碍.
- 老年病的医生 老年病的医生
背景情况:
- 患有和智力障碍 (ID) 的成年人面临认知和适应能力下降的风险.
- 潜在的遗传性疾病,发作和并发症有助于这些风险.
研究的目的:
- 重新评估和ID的成年人的适应性和认知功能.
- 分析随着时间的推移而发生的功能变化,并确定相关因素.
主要方法:
- 对患有耐药性和轻度至重度的成年人进行后续研究.
- 使用了维尼兰适应性行为量表 (VABS-II),韦克斯勒成人智力量表简体形式 (WAIS-SF-IV) 和图片皮博迪词汇测试 (PPVT-III).
- 通过混合效应模型和可靠的变化指数分析了变化;通过Chi平方测试探索了并发症.
主要成果:
- 适应性功能 (日常和社会技能) 的原始分数显著下降.
- 在重新评估的77.8%个体中,认知功能保持稳定.
- 16.7%的人在临床上怀疑患有痴呆症;与适应能力下降和疑似痴呆症相关的感官障碍.
结论:
- 这项研究揭示了和智障成年人的早期适应能力显著下降.
- 强调需要提高意识和更频繁的重新评估.
- 突出了感官障碍在功能衰退和痴呆风险中的作用.
相关概念视频
Cognitive Development During Adulthood
1.0K
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
1.0K
Epilepsy and Seizures: Overview
1.6K
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.6K
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
1.1K
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
1.1K
Intellectual Disability
944
Intellectual disability (ID) is a neurodevelopmental condition characterized by deficits in intellectual and adaptive functioning that manifest during the developmental period. This condition encompasses challenges in reasoning, memory, problem-solving, and learning, accompanied by impairments in everyday life skills, such as communication, self-care, and social interactions. Intellectual disability affects approximately 1% of the population in the United States, impacting an estimated 5...
944
Revisionist Views of Adolescent and Adult Cognition
358
A revisionist approach to Jean Piaget's theory of cognitive development has brought new insights that challenge and reinterpret his established ideas. Piaget proposed that the formal operational stage, emerging in adolescence, represents the culmination of cognitive maturity. During this stage, individuals are said to develop abstract thinking, engage in systematic problem-solving, and show a form of egocentrism, believing others are as preoccupied with their behavior as they are...
358
Antiepileptic Drugs: Potassium Channel Activators
880
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
880


